ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 153 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $750,000 | +118.7% | 26,000 | +141.1% | 0.42% | +23.1% |
Q3 2016 | $343,000 | -57.8% | 10,785 | -56.9% | 0.34% | -68.0% |
Q2 2016 | $812,000 | +30.1% | 25,000 | +42.9% | 1.07% | +176.7% |
Q4 2015 | $624,000 | -40.4% | 17,500 | -30.0% | 0.39% | -40.7% |
Q2 2015 | $1,047,000 | +36.7% | 25,000 | +6.4% | 0.65% | +27.4% |
Q1 2015 | $766,000 | -41.2% | 23,500 | -42.7% | 0.51% | -27.1% |
Q4 2014 | $1,302,000 | +3.1% | 41,000 | -19.6% | 0.70% | -21.5% |
Q3 2014 | $1,263,000 | -0.2% | 51,000 | -8.9% | 0.89% | +13.6% |
Q2 2014 | $1,265,000 | -24.1% | 56,000 | -18.2% | 0.79% | -12.7% |
Q1 2014 | $1,667,000 | -11.0% | 68,500 | -8.7% | 0.90% | -0.6% |
Q4 2013 | $1,874,000 | -24.2% | 75,000 | -16.7% | 0.90% | -40.1% |
Q3 2013 | $2,473,000 | +51.3% | 90,000 | 0.0% | 1.51% | +30.2% |
Q2 2013 | $1,634,000 | – | 90,000 | – | 1.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |